Manjari Lal
age ~56
from Redmond, WA
- Also known as:
-
- Manjari Kudallur
- Phone and address:
- 9524 225Th Way NE, Redmond, WA 98053
Manjari Lal Phones & Addresses
- 9524 225Th Way NE, Redmond, WA 98053
- Mcminnville, TN
- Bellevue, WA
- Piscataway, NJ
- San Francisco, CA
- Halethorpe, MD
- Buffalo, NY
- Edison, NJ
Work
-
Company:PathJul 2019
-
Position:Program advisor formulation technologies for vaccines and drugs
Education
-
School / High School:State University of New York College at Buffalo
Industries
Philanthropy
Us Patents
-
Vitamin E Conjugates
view source -
US Patent:6858227, Feb 22, 2005
-
Filed:Nov 20, 2002
-
Appl. No.:10/300678
-
Inventors:Manjari Lal - Bellevue WA, US
Yuehua Zhang - Mill Creek WA, US
Nagesh Palepu - Mill Creek WA, US -
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:A61K009/08
A61K009/107
A61K009/127
A61K031/4015
C07D407/12 -
US Classification:424450, 424455, 514422, 514424, 548525, 548543
-
Abstract:Vitamin E conjugates, methods for their preparation, and compositions that include the conjugates. The vitamin E conjugates include a tocopherol moiety covalently coupled through a linker moiety to either a pyroglutamate moiety, a pyrrolidinone moiety, or a gentisic acid moiety.
-
Fluorinated Compounds
view source -
US Patent:6864386, Mar 8, 2005
-
Filed:Nov 20, 2002
-
Appl. No.:10/300676
-
Inventors:Yuehua Zhang - Mill Creek WA, US
Manjari Lal - Bellevue WA, US
Andrew Leo - Kirkland WA, US
Nagesh Palepu - Mill Creek WA, US -
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07C069/34
-
US Classification:560197, 560192, 564123, 564192, 564193, 564199
-
Abstract:Fluorinated compounds and emulsions including the compounds. The compositions are useful as oxygen carriers and surfactants. In one embodiment, the fluorinated compound is pH sensitive. In one embodiment, the fluorinated compound is a vitamin E derivative. In one embodiment, the fluorinated compound is a vitamin K derivative.
-
Platinum Compounds
view source -
US Patent:7038071, May 2, 2006
-
Filed:Jul 16, 2003
-
Appl. No.:10/622007
-
Inventors:Manjari Lal - Bellevue WA, US
-
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07F 15/00
A61K 31/28 -
US Classification:556136, 514492
-
Abstract:Platinum compounds, pharmaceutically acceptable salts, and prodrugs thereof. Compositions that include the platinum compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier. Methods for using the platinum compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
-
Fluorinated Compounds
view source -
US Patent:7091374, Aug 15, 2006
-
Filed:Apr 23, 2004
-
Appl. No.:10/830751
-
Inventors:Yuehua Zhang - Mill Creek WA, US
Manjari Lal - Bellevue WA, US
Andrew Leo - Kirkland WA, US
Nagesh Palepu - Mill Creek WA, US -
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07C 231/00
-
US Classification:560129, 564156, 564160, 568681, 568683
-
Abstract:Fluorinated compounds and emulsions including the compounds. The compositions are useful as oxygen carriers and surfactants. In one embodiment, the fluorinated compound is pH sensitive. In one embodiment, the fluorinated compound is a vitamin E derivative. In one embodiment, the fluorinated compound is a vitamin K derivative.
-
Platinum Carboxylate Anticancer Compounds
view source -
US Patent:7129368, Oct 31, 2006
-
Filed:Mar 14, 2005
-
Appl. No.:11/080348
-
Inventors:Manjari Lal - Redmond WA, US
-
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07F 15/00
A61K 31/28 -
US Classification:556137, 514492
-
Abstract:Platinum carboxylate anticancer compounds, pharmaceutical compositions that include the platinum carboxylate compounds, and methods for treating cellular proliferative diseases by administering the platinum carboxylate compounds.
-
Platinum Compounds
view source -
US Patent:7232919, Jun 19, 2007
-
Filed:Dec 19, 2005
-
Appl. No.:11/311909
-
Inventors:Manjari Lal - Bellevue WA, US
-
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07F 15/00
A61K 31/28 -
US Classification:556136, 514492
-
Abstract:Platinum compounds, pharmaceutically acceptable salts, and prodrugs thereof. Compositions that include the platinum compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier. Methods for using the platinum compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
-
Multinuclear Platinum Compounds
view source -
US Patent:7268245, Sep 11, 2007
-
Filed:Oct 18, 2006
-
Appl. No.:11/550546
-
Inventors:Manjari Lal - Redmond WA, US
Lynn C. Gold - Seattle WA, US -
Assignee:Sonus Pharmaceuticals, Inc. - Bothell WA
-
International Classification:C07F 15/00
A61K 31/28 -
US Classification:556137, 514492
-
Abstract:Multinuclear platinum compounds, compositions that include the platinum compounds, methods for making the platinum compounds, and methods for treating cellular proliferative diseases by administering the platinum compounds.
-
Tocopherol Derivatives
view source -
US Patent:20030149099, Aug 7, 2003
-
Filed:Feb 5, 2002
-
Appl. No.:10/068806
-
Inventors:Yuehua Zhang - Mill Creek WA, US
Manjari Lal - Bellevue WA, US
Nagesh Palepu - Mill Creek WA, US -
Assignee:Sonus Pharmaceuticals, Inc.
-
International Classification:A61K031/355
C 07D 4 5/14 -
US Classification:514/458000, 549/408000
-
Abstract:Tocopherol derivatives are provided. In one embodiment, the tocopherol derivative includes a tocopherol moiety covalently coupled to branched hydrophilic moiety. In another embodiment, the tocopherol derivative includes a first tocopherol moiety covalently coupled to a second tocopherol moiety through a hydrophilic moiety. In other embodiments, the derivative includes three or more tocopherol moieties.
Resumes
Program Advisor Formulation Technologies For Vaccines And Drugs
view sourceLocation:
Seattle, WA
Industry:
Philanthropy
Work:
Path
Program Advisor Formulation Technologies For Vaccines and Drugs
Path Dec 2017 - Jul 2019
Portfolio Leader Formulation Technologies
Path Dec 2017 - Jul 2019
Senior Research Officer
Path Dec 2017 - Jul 2019
Technical Officer
Sonus Pharma Nov 2000 - Mar 2008
Research Scientist Iii
Program Advisor Formulation Technologies For Vaccines and Drugs
Path Dec 2017 - Jul 2019
Portfolio Leader Formulation Technologies
Path Dec 2017 - Jul 2019
Senior Research Officer
Path Dec 2017 - Jul 2019
Technical Officer
Sonus Pharma Nov 2000 - Mar 2008
Research Scientist Iii
Education:
State University of New York College at Buffalo
Get Report for Manjari Lal from Redmond, WA, age ~56